ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00561197
Recruitment Status : Terminated (Drug not being developed for this indication)
First Posted : November 20, 2007
Last Update Posted : January 4, 2013
Sponsor:
Information provided by:
Ascenta Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2010
  Actual Study Completion Date : September 2010